glp 1 drug novo nordisk promotes new GLP-1 receptor agonist to fight diabetes, obesity < Pharma < Article Novo Nordisk justifies reasoning behind
Description
Some studies link GLP-1 use to an increased risk for eye diseases but a recent paper argues there is insufficient evidence to suggest drugs like Ozempic contribute to vision loss.
IntroductionWith the rise in glucagon-like peptide 1 receptor agonist (GLP-1RA) medication usage for Type 2 diabetes mellitus and weight loss, concerns have ...
Free from dyes, chemicals and allergens
Rita Kapoor in Frederick, MD
Shima Hadidchi, MD, in Apple Valley and Victorville, CA
Farxiga can cost up to $600 without insurance, depending on the pharmacy and brand choice
